These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 3882227

  • 1. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
    Eggermont AM, Weimar W, Marquet RL, Laméris JD, Jeekel J.
    Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
    Lillis PK, Brown TD, Beougher K, Koeller J, Marcus SG, Von Hoff DD.
    Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
    [Abstract] [Full Text] [Related]

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA, Callaghan M, Sarna G.
    Cancer Treat Rep; 1983 May 15; 67(5):493-4. PubMed ID: 6850664
    [Abstract] [Full Text] [Related]

  • 5. High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses.
    Krown SE, Mintzer D, Cunningham-Rundles S, Niedzwiecki D, Krim M, Einzig AI, Gabrilove JL, Shurgot B, Gessula J.
    Cancer Treat Rep; 1987 Jan 15; 71(1):39-45. PubMed ID: 3791267
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T, Laszlo J, Moore J, Silverman P.
    Cancer Treat Rep; 1983 Nov 15; 67(11):1009-12. PubMed ID: 6640552
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 8. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
    Vugrin D, Hood L, Laszlo J.
    J Biol Response Mod; 1986 Aug 15; 5(4):309-12. PubMed ID: 3734846
    [Abstract] [Full Text] [Related]

  • 9. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [Abstract] [Full Text] [Related]

  • 10. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H.
    Gan To Kagaku Ryoho; 1985 Aug 15; 12(8):1625-9. PubMed ID: 3896154
    [Abstract] [Full Text] [Related]

  • 11. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
    Figlin RA, deKernion JB, Maldazys J, Sarna G.
    Cancer Treat Rep; 1985 Mar 15; 69(3):263-7. PubMed ID: 3978656
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis and surgical treatment of metastatic lung tumors].
    Yamamoto Y, Hirata T, Fukuse T, Yokomise H, Ike O, Mizuno H, Wada H, Hitomi S, Nakamura T, Shimizu Y.
    Gan To Kagaku Ryoho; 1996 Sep 15; 23(10):1248-54. PubMed ID: 8831735
    [Abstract] [Full Text] [Related]

  • 13. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR, Aghajanian C, Barakat RR, Fennelly D, Shapiro F, Spriggs D.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM, Silver HK.
    Cancer Treat Rep; 1984 Sep 15; 68(9):1093-6. PubMed ID: 6478449
    [Abstract] [Full Text] [Related]

  • 15. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 15; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH, Cheng AL, Lin MT, Hong RL, Hsu CH, Lin JF, Chang KJ, Lee PH, Chen YC.
    Anticancer Res; 1997 Oct 15; 17(5B):3867-71. PubMed ID: 9427794
    [Abstract] [Full Text] [Related]

  • 17. Minimal activity of recombinant clone a interferon in metastatic colon cancer.
    Neefe JR, Silgals R, Ayoob M, Schein PS.
    J Biol Response Mod; 1984 Aug 15; 3(4):366-70. PubMed ID: 6481401
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 15; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 19. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Tixi LM, Bolli EA, Rosso R, Mammoliti S, Rollandi GA, Bertoglio S.
    Clin Cancer Res; 1995 Sep 15; 1(9):955-60. PubMed ID: 9816066
    [Abstract] [Full Text] [Related]

  • 20. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS, Mangalik A, Ferguson J, Elias L.
    Clin Cancer Res; 1995 Jun 15; 1(6):615-20. PubMed ID: 9816023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.